Yamato, Japan

Tadao Takeuchi

This inventor holds 1 USPTO granted patent. Top assignee: Minophagen Pharmaceutical Co., Ltd.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadao Takeuchi. Retrieved from https://idiyas.com/inventor/tadao-takeuchi-lvmte8vl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tadao Takeuchi: Innovator in Antihypertensive Methods

Introduction

Tadao Takeuchi is a notable inventor based in Yamato, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing antihypertensive methods. His innovative approach has the potential to improve the lives of many hypertensive patients.

Latest Patents

Takeuchi holds a patent for an antihypertensive method. This method involves administering a pharmaceutical agent containing lithospermic acid B, along with its pharmaceutically acceptable salts, to hypertensive patients. This innovative treatment aims to effectively manage hypertension and enhance patient outcomes.

Career Highlights

Tadao Takeuchi is associated with Minophagen Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in antihypertensive therapies. His work has garnered attention for its potential impact on public health.

Collaborations

Takeuchi has collaborated with notable colleagues, including Takako Yokozawa and Hikokichi Oura. These partnerships have contributed to the advancement of research in the pharmaceutical field.

Conclusion

Tadao Takeuchi's contributions to antihypertensive methods exemplify the importance of innovation in healthcare. His work continues to pave the way for new treatments that can significantly benefit patients suffering from hypertension.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…